The Accuracy of the Edmonton Symptom Assessment System for the Assessment of Depression in Patients With Cancer: A Systematic Review and Meta-Analysis

Abstract

Background:

Depression is a common health problem among patients with cancer. The Edmonton Symptom Assessment System (ESAS) is one of many tools that have been used to evaluate depression in these patients. Nevertheless, the diagnostic performance and the appropriate cutoff point of the ESAS for the assessment of depression in these patients have varied in the studies.

Purpose:

To determine the diagnostic accuracy and the optimal cutoff point for the ESAS for the assessment of depression in patients with cancer.

Data Sources:

PubMed, Scopus, CINAHL, and Cochrane library databases from inception to September 18, 2016.

Study Selection:

Paired reviewers independently screened abstracts and full-text articles for all cross-sectional studies published in English and compared these with the ESAS in the depression (ESAS-D) subscale with reference to standard tests for the assessment of depression.

Data Extraction:

Two reviewers serially abstracted the data and independently assessed the risk of bias by using the Quality Assessment of Diagnostic Accuracy Studies 2.

Data Synthesis:

A total of 6 studies were eligible for review. Our meta-analysis showed the optimal cutoff point of the ESAS-D ≥ 4, with pooled sensitivity and specificity at 53% (95% confidence interval [CI]: 38%-67%) and 90% (95% CI: 82%-94%), respectively. The positive likelihood ratio and diagnostic odds ratio of the ESAS-D ≥ 4 were 5.2 (95% CI: 3.1-8.6) and 10 (95% CI: 5-19). There was a high degree of heterogeneity between the studies (P value <.001, I ² = 96%).

Conclusion:

We suggest that an ESAS-D ≥ 4 could be used to detect possible cases of depression in patients with cancer.

Registration:

Our study protocol was registered with the International Prospective Register of Systematic Reviews on October 4, 2016, and was last updated on January 11, 2017 (registration number CRD42016048288).

Keywords

depression ESAS systematic review sensitivity cancer patients

Get full access to this article

View all access options for this article.

References

Ferrari

Charlson

Norman

. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. 2013;10(11):e1001547.

Oechsle

Goerth

Bokemeyer

Mehnert

. Anxiety and depression in caregivers of terminally ill cancer patients: impact on their perspective of the patients’ symptom burden. J Palliat Med. 2013;16(9):1095–1101.

Hotopf

Chidgey

Addington-Hall

. Depression in advanced disease: a systematic review Part 1. Prevalence and case finding. Palliat Med. 2002;16(2):81–97.

Mitchell

Chan

Bhatti

. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12(2):160–174.

American Psychiatric Association. DSM Task Force. Diagnostic and Statistical Manual of Mental Disorders: DSM-5; 2013. American Psychiatric Association Publishing.

Andersen

DeRubeis

Berman

. Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. J Clin Oncol. 2014;32(15):1605–1619.

Rayner

Price

Hotopf

Higginson

. The development of evidence-based European guidelines on the management of depression in palliative cancer care. Eur J Cancer. 2011;47(5):702–712.

Howell

Mayo

Currie

. Psychosocial health care needs assessment of adult cancer patients: a consensus-based guideline. Support Care Cancer. 2012;20(12):3343–3354.

Bruera

Kuehn

Miller

Selmser

Macmillan

. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care. 1991;7(2):6–9.

10.

Vignaroli

Pace

Willey

Palmer

Zhang

Bruera

. The Edmonton Symptom Assessment System as a screening tool for depression and anxiety. J Palliat Med. 2006;9(2):296–303.

11.

Rhondali

Perceau

Berthiller

. Frequency of depression among oncology outpatients and association with other symptoms. Support Care Cancer. 2012;20(11):2795–2802.

12.

Bagha

Macedo

Jacks

. The utility of the Edmonton Symptom Assessment System in screening for anxiety and depression. Eur J Cancer Care (Engl). 2013;22(1):60–69.

13.

Ripamonti

Bandieri

Pessi

Maruelli

Buonaccorso

Miccinesi

. The Edmonton Symptom Assessment System (ESAS) as a screening tool for depression and anxiety in non-advanced patients with solid or haematological malignancies on cure or follow-up. Support Care Cancer. 2014;22(3):783–793.

14.

Brenne

Loge

Lie

Hjermstad

Fayers

Kaasa

; European Palliative Care Research Collaborative (EPCRC). The Edmonton Symptom Assessment System: poor performance as screener for major depression in patients with incurable cancer. Palliat Med. 2016;30(6):587–598.

15.

Chinda

Jaturapatporn

Kirshen

Udomsubpayakul

. Reliability and validity of a Thai version of the Edmonton Symptom Assessment Scale (ESAS-Thai). J Pain Symptom Manage. 2011;42(6):954–960.

16.

Dong

Chen

Zheng

. Psychometric validation of the Edmonton Symptom Assessment System in Chinese patients. J Pain Symptom Manage. 2015;50(5):712–717.e712.

17.

Whiting

Rutjes

AWS

Westwood

. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–536.

18.

Yamaguchi

Morita

Nitto

. Establishing cutoff points for defining symptom severity using the Edmonton Symptom Assessment System-revised Japanese version. J Pain Symptom Manage. 2016;51(2):292–297.

19.

Hong

Tian

. Prevalence of anxiety and depression and their risk factors in Chinese cancer patients. Support Care Cancer. 2014;22(2):453–459.

20.

Hayes

Lee

Rayner

. Gender differences in prevalence of depression among patients receiving palliative care: the role of dependency. Palliat Med. 2012;26(5):696–702.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.23 MB